Press releases
- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
- Edwards Lifesciences to Acquire Innovalve
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
More ▼
Key statistics
On Friday, Edwards Lifesciences Corp (EWL:BRN) closed at 83.18, 0.00% below its 52-week high of 83.18, set on Apr 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 83.18 |
---|---|
High | 83.18 |
Low | 83.18 |
Bid | 83.18 |
Offer | 83.46 |
Previous close | 83.18 |
Average volume | -- |
---|---|
Shares outstanding | 602.60m |
Free float | 597.19m |
P/E (TTM) | 37.53 |
Market cap | 52.61bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of Apr 05 2024.
More ▼